Oberweis Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.52M Buy
114,666
+12,601
+12% +$1.05M 0.41% 86
2025
Q1
$8.56M Sell
102,065
-240
-0.2% -$20.1K 0.43% 84
2024
Q4
$9.43M Buy
102,305
+1,601
+2% +$148K 0.44% 86
2024
Q3
$9.35M Buy
100,704
+1
+0% +$93 0.48% 82
2024
Q2
$8.29M Buy
100,703
+20,702
+26% +$1.7M 0.51% 76
2024
Q1
$5.31M Buy
80,001
+14,701
+23% +$976K 0.38% 103
2023
Q4
$3.71M Buy
65,300
+8,300
+15% +$471K 0.35% 114
2023
Q3
$3.11M Buy
57,000
+25,400
+80% +$1.38M 0.33% 119
2023
Q2
$2.13M Buy
31,600
+2,900
+10% +$195K 0.26% 127
2023
Q1
$1.48M Buy
28,700
+7,100
+33% +$365K 0.23% 137
2022
Q4
$994K Buy
21,600
+7,300
+51% +$336K 0.21% 133
2022
Q3
$725K Buy
+14,300
New +$725K 0.17% 134